Loading...
Market
Will there be a change in Kenvue's executive leadership by mid-2025 due to strategic changes?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
Official company announcements and credible business news sources
Story
Kenvue Stock Rises 4.7% on Earnings Beat, Plans 4% Workforce Cut
May 7, 2024, 12:24 PM
Kenvue, a consumer health company known for products like Tylenol and Band-Aid, reported a strong performance in the first quarter, surpassing Wall Street estimates. The company announced a 4.7% increase in stock value following the earnings report that exceeded expectations with a Non-GAAP EPS of $0.28, beating by $0.03, and revenue of $3.9 billion, which was $110 million above forecasts. Concurrently, Kenvue disclosed plans to cut 4% of its global workforce as part of an efficiency initiative aimed at enhancing competitiveness.
View original story
Similar markets
No change in leadership • 34%
CEO replaced • 33%
CFO replaced • 33%
No change • 33%
New CEO • 33%
Change in other top management • 34%
CEO Change • 25%
CFO Change • 25%
CTO Change • 25%
No Change • 25%
No change • 25%
New CEO appointed • 25%
Major board reshuffle • 25%
Leadership remains but restructured • 25%
No change in leadership • 25%
New CEO appointed • 25%
New CFO appointed • 25%
Overhaul of entire executive team • 25%
No change • 33%
New CEO • 33%
New senior executives • 33%
CEO change • 25%
CFO change • 25%
COO change • 25%
No major changes • 25%
